Results 11 to 20 of about 20,836,880 (230)
Non-vitamin K antagonist oral anticoagulants for heart diseases [PDF]
Терапевтический архив, 2017 Non-vitamin K antagonist oral anticoagulants (NОАСs) are highly effective drugs that prevent venous thrombosis and stroke in atrial fibrillation. Their use has difficulties that are associated with the need for laboratory control and with the influence ...
T B Kondratieva, L V Popova, I N Bokarev
doaj +4 more sources
An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
Advances in Hematology, 2020 Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban.
Mark Terence P. Mujer +7 more
doaj +4 more sources
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants [PDF]
Data in Brief, 2018 This article contains the data showing the different characteristics of atrial fibrillation (AF) patients treated with vitamin K (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs) screened for the presence of liver fibrosis (LF) and followed ...
Daniele Pastori +9 more
doaj +2 more sources
Non-vitamin K antagonist oral anticoagulants and sport
Minerva Cardioangiologica, 2020 Physical activity is worldwide recommended for its benefits on cardiovascular system. There is an increasing number of people of all ages that approach sport activity both as leisure time physical activity and as competitive sport. It is always more frequent the request even from older subjects and cardiac patients to be allowed to practice physical ...
Romano S. +5 more
openaire +3 more sources
Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease
Hämostaseologie, 2021 AbstractThe prevention of atherothrombotic events is the primary goal in the treatment of patients with arteriosclerotic disorders. Despite recent improvements in the management of coronary artery disease (CAD) with revascularization techniques and antiplatelet therapy, some patients remain at risk of recurrent cardiovascular events.
Samer, Al Said +3 more
openaire +3 more sources
Journal of Osteoporosis, 2019 Although known for its importance in the coagulation cascade, vitamin K has other functions. It is an essential vitamin for bone health, taking part in the carboxylation of many bone-related proteins, regulating genetic transcription of osteoblastic ...
Celia Rodríguez-Olleros Rodríguez +1 more
doaj +2 more sources
Clinical Interventions in Aging, 2015 Mohit K Turagam, Poonam Velagapudi, Greg C FlakerDivision of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, MO, USAAbstract: Stroke prevention in elderly atrial fibrillation patients remains a challenge.
Turagam MK, Velagapudi P, Flaker GC
doaj +1 more source
Comparison of ََQuality of Life and Treatment Satisfaction among Sample of Iraqi Patients Using Anticoagulant Therapy (Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants) [PDF]
مجلة كلية الطبBackground: Oral anticoagulation medication, warfarin and non-vitamin k antagonist oral anticoagulants (NOAC) may require long term use which may affect patients’ satisfaction with their treatment and their quality of life (QOL). Objective: To compare
Basma Z. Al-Metwali, Tuqa M. AL-Ameen
doaj +2 more sources
Vitamin K antagonist use and renal function in pre-dialysis patients
Clinical Epidemiology, 2018 Pauline WM Voskamp,1 Friedo W Dekker,1 Maarten B Rookmaaker,2 Marianne C Verhaar,2 Willem Jan W Bos,3 Merel van Diepen,1 Gurbey Ocak2 1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; 2Department of ...
Voskamp PWM +6 more
doaj +1 more source
PLoS ONE, 2015 BackgroundUse of the non-vitamin K antagonist oral anticoagulants (NOACs) is endorsed by current guidelines for stroke prevention in patients with atrial fibrillation (AF).
Giuseppe Santarpia +6 more
doaj +2 more sources